Sivik Global Healthcare LLC Makes New $2.63 Million Investment in Avantor, Inc. $AVTR

Sivik Global Healthcare LLC acquired a new stake in Avantor, Inc. (NYSE:AVTR) in the third quarter, HoldingsChannel reports. The institutional investor acquired 175,000 shares of the company’s stock, valued at approximately $2,634,000. Avantor makes up about 1.6% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its 27th largest position.

Several other large investors also recently modified their holdings of AVTR. Elevation Wealth Partners LLC boosted its holdings in Avantor by 72.3% in the third quarter. Elevation Wealth Partners LLC now owns 2,803 shares of the company’s stock valued at $42,000 after purchasing an additional 1,176 shares during the last quarter. SJS Investment Consulting Inc. boosted its stake in shares of Avantor by 1,599.7% during the 1st quarter. SJS Investment Consulting Inc. now owns 5,235 shares of the company’s stock valued at $41,000 after buying an additional 4,927 shares during the last quarter. IFP Advisors Inc grew its position in shares of Avantor by 901.4% during the second quarter. IFP Advisors Inc now owns 5,858 shares of the company’s stock worth $58,000 after buying an additional 5,273 shares in the last quarter. State of Wyoming acquired a new stake in shares of Avantor during the second quarter worth approximately $74,000. Finally, Parallel Advisors LLC increased its stake in shares of Avantor by 21.4% in the first quarter. Parallel Advisors LLC now owns 8,452 shares of the company’s stock worth $66,000 after buying an additional 1,491 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on AVTR shares. TD Cowen upped their price target on shares of Avantor from $15.00 to $17.00 and gave the company a “hold” rating in a report on Tuesday. Royal Bank Of Canada boosted their price target on Avantor from $9.00 to $14.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. Barclays lifted their price objective on shares of Avantor from $13.00 to $15.00 and gave the stock an “underweight” rating in a report on Wednesday, October 7th. Citigroup boosted their price objective on Avantor from $9.00 to $11.00 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. Finally, Morgan Stanley upped their price target on shares of Avantor from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Two research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Avantor presently has a consensus rating of “Hold” and an average target price of $13.24.

Avantor Price Performance

AVTR stock traded up $0.07 during trading hours on Tuesday, hitting $15.56. 1,180,025 shares of the stock traded hands, compared to its average volume of 10,054,715. The stock has a 50-day simple moving average of $14.71 and a 200 day simple moving average of $11.19. The company has a market cap of $10.53 billion, a P/E ratio of -18.53, a P/E/G ratio of 11.83 and a beta of 0.94. Avantor, Inc. has a one year low of $7.26 and a one year high of $16.38. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.65.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.19 by $0.02. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The firm had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.61 billion. During the same period in the previous year, the business earned $0.24 earnings per share. Avantor’s revenue for the quarter was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Equities analysts forecast that Avantor, Inc. will post 0.81 earnings per share for the current year.

Avantor Company Profile

Avantor, Inc is a global provider of products, services and solutions used in the life sciences and advanced technology industries. The company supplies materials and equipment that support research, drug discovery and development, biopharmaceutical manufacturing, clinical and diagnostic activities, and other laboratory applications.

Its offerings include laboratory chemicals and reagents, consumables, single-use manufacturing technologies, bioprocessing products, equipment, and related services.